NCT03330314View on ClinicalTrials.gov

Molar Potency Study of HM12460A in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 24, 2017

Primary Completion Date

February 8, 2018

Study Completion Date

February 8, 2018

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

HM12460A

HM12460A is a long-acting insulin

Trial Locations (1)

91911

Hanmi Investigative Site, Chula Vista

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT03330314 - Molar Potency Study of HM12460A in Healthy Subjects | Biotech Hunter | Biotech Hunter